Concepedia

Yong Ben

YB

Statistics

Publications

22

Citations

1.6K

H-Index

17

Active since

2002

Affiliations

AstraZeneca (United States)(Current)

California Pacific Medical Center

BioAtla (United States)

Zhongshan Hospital

Fudan University

Yong Ben is an author at AstraZeneca (United States) specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

2002–2020

22

Publications

22

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma

Thomas Powles, Peter H. O’Donnell, Christophe Massard et al. · JAMA Oncology · 2017 · 846 citations

Medicine, Oncology, Pharmacotherapy +17

Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status

Paul Baverel, Vincent F. S. Dubois, Chao Yu Jin et al. · Clinical Pharmacology & Therapeutics · 2017 · 151 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue

Shanaz H. Dairkee, Youngran Ji, Yong Ben et al. · BMC Genomics · 2004 · 62 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Population Modeling of Tumor Kinetics and Overall Survival to Identify Prognostic and Predictive Biomarkers of Efficacy for Durvalumab in Patients With Urothelial Carcinoma

Yanan Zheng, Rajesh Narwal, ChaoYu Jin et al. · Clinical Pharmacology & Therapeutics · 2017 · 57 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Upregulation of AQP3 and AQP5 induced by dexamethasone and ambroxol in A549 cells

Yong Ben, Jie Chen, Rong Zhu et al. · Respiratory Physiology & Neurobiology · 2008 · 44 citations

Life Sciences, Cell Biology, Pharmacology +7

1–5 of 22